Filing Details
- Accession Number:
- 0000880771-16-000200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-27 13:00:06
- Reporting Period:
- 2016-10-25
- Filing Date:
- 2016-10-27
- Accepted Time:
- 2016-10-27 13:00:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291656 | Wai-Shun Wilson Cheung | 950 Tower Lane, Suite 900 Foster City CA 94404 | Cfo & Senior Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-10-25 | 70 | $10.00 | 15,064 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-10-26 | 15,064 | $10.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-10-26 | 45,208 | $4.52 | 45,208 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-10-26 | 45,208 | $10.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-10-26 | 48,995 | $5.97 | 48,995 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-10-26 | 48,995 | $10.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-10-26 | 40,625 | $5.97 | 40,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-10-26 | 40,625 | $10.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-10-26 | 45,208 | $0.00 | 45,208 | $4.52 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-10-26 | 40,625 | $0.00 | 40,625 | $5.97 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-10-26 | 48,995 | $0.00 | 48,995 | $5.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,792 | 2024-03-14 | No | 4 | M | Direct | |
| 9,375 | 2023-07-16 | No | 4 | M | Direct | |
| 0 | 2023-08-09 | No | 4 | M | Direct |
Footnotes
- The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2016.
- Granted under the Issuer's 2005 Equity Incentive Plan.
- 25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
- Provided Reporting Person remains employed by Issuer, the options will vest based upon the successful and timely filing by the SEC filing dates of the 10-Q and 10-Ks for the period from September 30, 2013 through the end of 2014, with the last 10-K filed for the year ending December 31, 2014 by March 16, 2015 (the "Performance Target"). If the Performance Target is not achieved, the options will not vest and will expire on March 17, 2015.
Billionaire Hedge Funds
